Results: awareness about chemoprevention – with Cancer Research UK

The study “GP awareness about chemoprevention” was carried out on behalf of Cancer Research UK, and aimed to specifically explore GP awareness on tamoxifen and aspirin use with breast and bowel cancers.

The survey took place in May 2016 in the UK and involved over 1,000 physicians from our panel. You can access the study here and see a summary together with the main findings below.

Leave a Reply

Join Today

Registration is free and only takes a few clicks

Panel Members

Check your available studies

latest posts

emerging respiratory treatments for lung cancer - cystic fibrosis - robotic navigation - gene-editing nanoparticles

Emerging Respiratory Treatments: Frontiers in Pulmonology

Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.

Paid Studies About Medical Devices | M3 Guide

Real-World Evidence studies collect real-world data to evaluate the safety and performance of medical devices. This M3 Guide reveals how we conduct Real-World Evidence studies, how they contribute to better patient outcomes, and how healthcare professionals can get compensated.